Sachie Hirai
Sapporo, 0608556, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
A Newly Developed Anti-L1CAM Monoclonal Antibody Targets Small Cell Lung Carcinoma Cells.
Journal: International journal of molecular sciences
Published: June 26, 2024
Small Cell Lung Carcinoma Cells Depend on KIF11 for Survival.
Journal: International journal of molecular sciences
Published: May 01, 2024
Dual inhibition of KIF11 and BCL2L1 induces apoptosis in lung adenocarcinoma cells.
Journal: Biochemical and biophysical research communications
Published: August 02, 2023
Junctional adhesion molecule 3 is a potential therapeutic target for small cell lung carcinoma.
Journal: Experimental cell research
Published: January 29, 2023
Dual inhibition of BCL2L1 and MCL1 is highly effective against RET fusion-positive or MET exon 14 skipping mutation-positive lung adenocarcinoma cells.
Journal: Biochemical and biophysical research communications
Published: September 01, 2022
Anthrax toxin receptor 2 is a potential therapeutic target for non-small cell lung carcinoma with MET exon 14 skipping mutations.
Journal: Experimental cell research
Published: December 20, 2021
MCL1 inhibition enhances the efficacy of docetaxel against airway-derived squamous cell carcinoma cells.
Journal: Experimental cell research
Published: April 14, 2021
Pericyte-myofibroblast transition in the human lung.
Journal: Biochemical and biophysical research communications
Published: April 13, 2020
EGFR-independent EGFR-mutant lung adenocarcinoma cells depend on Bcl-xL and MCL1 for survival.
Journal: Biochemical and biophysical research communications
Published: March 04, 2020
MCL1 inhibition enhances the therapeutic effect of MEK inhibitors in KRAS-mutant lung adenocarcinoma cells.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 13, 2018
Characterization of distal airway stem-like cells expressing N-terminally truncated p63 and thyroid transcription factor-1 in the human lung.
Journal: Experimental cell research
Published: July 10, 2018
Trametinib downregulates survivin expression in RB1-positive KRAS-mutant lung adenocarcinoma cells.
Journal: Biochemical and biophysical research communications
Published: April 26, 2018
Last Updated: 09/26/2026